Analysis of the Strong Performance of Kangtuo Medical (688314)

Kangtuo Medical (688314) has recently entered the strong stock pool, and its strong performance can be analyzed from multiple dimensions:

• Catalyst
  : The product of an enterprise invested by the company has obtained US FDA certification (involving brain-computer interface technology), coupled with news related to Musk’s Neuralink, driving up the popularity of the BCI concept sector [1][2].
• Technical Aspect
  : On January 5, it achieved a 19.99% daily limit with a trading volume of 76,400 hands (far exceeding the historical average of 500,000 hands daily) and a turnover rate of 9.41% [0][1]; On January 6, it opened to challenge the high of $43.63, closed at $42.71 with a daily increase of 7.66%, and trading volume further rose to 80,100 hands [0].
• Fundamental Aspect
  : The company’s PEEK material technology is widely applied in neurosurgery and maxillofacial repair fields, and is regarded as a potential target in the high-end medical materials track [2].

1. Indirect Impact of BCI Concept
   : The strength of Kangtuo Medical is not based on its own BCI breakthrough, but on the resonance between the FDA certification of the invested enterprise and industry hotspots. Attention should be paid to the uncertainty of subsequent substantive benefits.
2. Capital and Sentiment Driven
   : The main capital net bought 41.1791 million yuan on January 5 [1], combined with the popularity of the BCI concept, driving a short-term increase of 28.72% over 5 trading days [0].

• Risks
  : The current PE is 39.25 times, which is at a relatively high level in the industry [0]; The BCI catalysis is highly indirect, and the accumulation of short-term profit-taking may trigger a correction.
• Opportunities
  : PEEK material technology has long-term application prospects; if it can be effectively transformed into product competitiveness, it may support long-term valuation.

Kangtuo Medical’s recent strength is driven by BCI concept catalysis and capital sentiment, with a significant increase in trading volume on the technical side, and its fundamentals rely on the advantages of PEEK material technology. Investors should pay attention to the $39.67 support level and $43.63 resistance level [0], while being alert to risks brought by valuation and indirect catalysis.